Associations between central obesity and indexes of hemostatic, carbohydrate and lipid metabolism. Results of a 1-year intervention from the Oslo Diet and Exercise Study

Scandinavian Journal of Medicine and Science in Sports

Volumn 8, Issue 2, 1998, Pages 109-115

  Anderssen, S A ^a   Holme, I ^a,b   Urdal, P ^b   Hjermann, I ^b  

^a NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Central obesity; Fibrinolysis; Insulin; Lipids; Physical fitness; Waist circumference

Indexed keywords

BLOOD CLOTTING FACTOR 7; GLUCOSE; INSULIN; SERUM GLOBULIN;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; BODY CONSTITUTION; BODY MASS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIET THERAPY; FEMALE; FITNESS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; INTERVENTION STUDY; KINESIOTHERAPY; LIPID METABOLISM; LOW CALORY DIET; MALE; METABOLISM; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; BLOOD COAGULATION; BLOOD GLUCOSE; BODY CONSTITUTION; BODY MASS INDEX; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIET, REDUCING; EXERCISE THERAPY; FACTOR VII; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HEMOSTASIS; HUMANS; INSULIN; INTERVENTION STUDIES; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PHYSICAL FITNESS; REGRESSION ANALYSIS; RISK FACTORS; SERUM GLOBULINS;

EID: 0032042321     PISSN: 09057188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0838.1998.tb00177.x     Document Type: Article

References (31)

1. Yao C-H, Slattcry ML, Jacobs DR, Folsom AR, Nelson ET. Anthropometric predictors of coronary heart disease and total mortality: Findings from the US Railroad study. Am J Epidemiol 1991: 134: 1278-89.
2. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjørntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death 13 year follow up of participants in the study of men born in 1913. Br Med J 1984: 288: 1401-4.
3. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjøstrøm L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984: 289: 1257-61.
4. Larsson B. Fat distribution and risk for death, myocardial infarction and stroke. In: Fat distribution during growth and later health outcomes. New York. Alan R. Liss, Inc., 1988: 193-201.
5. Seidell JC, Björntorp P, Sjöström L, Kvist H, Sannerstedt R. Viceral fat accumulation in men is positively associated with insulin, glucose, and c-peptide levels, but negatively with testosterone levels. Metabolism 1990: 39: 897-901.
6. Sundell IB, Nilsson TK, Hallmans G, Hellsten G, Dahlèn GH. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 1989: 80: 9-16.
7. Houmard JA, Wheeler WS, McCammon MR, Holbert D, Israel RG, Barakat HA. Effects of fitness level and the regional distribution of fat on carbohydrate metabolism and plasma lipids in middle- to older-aged men. Metabolism 1991: 40: 714-19.
8. Coon PJ, Bleecker ER, Drinkwater DT, Meyers DA, Goldberg AP. Effects of body composition and exercise capacity on glucose tolerance, insulin, and lipoprotein lipids in healthy older men: A cross-sectional and longitudinal intervention study. Metabolism 1989: 38: 1201-9.
9. Bonithon-Kopp C, Raison J, Egloff M, Guy-Grand B, Ducimetière P. Skinfold and body circumferences as measures of body fat patterning in a French female active population: relationships with the metabolic risk profile. J Clin Epidemiol 1991: 44: 475-82.
10. Licata G, Scaglione R, Ganguzza A, et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. AJH 1994: 7: 314-20.
11. Kaye SA, Folsom AR, Sprafka JM, Prineas RJ, Wallace RB. Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 1991: 44: 329-34.
12. Landin K, Stigendal L, Eriksson E, et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990: 39: 1044-8.
13. Kumagai S, Tanaka H, Kitajima H, et al. Relationships of lipid and glucose metabolism with waist-hip ratio and physical fitness in obese men. International Journal of Obesity 1993: 17: 437-40.
14. Connelly JB, Cooper JA, Meade TW. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 1992: 67: 351-4.
15. Folsom AR, Qamhieh HT, Wing RR. et al. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arteriosclerosis and Thrombosis 1993: 13: 162-9.
16. Wing RR, Jeffery RW, Burton LR, Thorson C, Kuller LH, Folsom AR. Change in waist:hip ratio with weight loss and its association with change in cardiovascular risk factors. Am J Clin Nutr 1992: 55: 1086-92.
17. The ODES investigators. The Oslo Diet and Exercise Study (ODES): Design and Objectives. Controlled Clinical Trials 1993: 14: 229-43.
18. McLean KP, Skinner JS. Validity of Futrex-5000 for body composition determination. Med Sci Sports Exerc 1992: 24: 253-258.
19. Balke B. Optimale Körperliche Leistungsfähigkeit, ihre Messung und Veräderung infolge Arbeitsermüdung. Arbeitsphysiologie 1954: 15: 311-23.
20. Nordby E, Arnesen H, Andersen P, Godal HC. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis. Scand J Haematol 1980: 25: 407-11.
21. Anderssen SA, Haaland A, Hjermann I, Urdal P, Gjesdal K, Holme I. Oslo Diet and Exercise Study: A one year randomized intervention trial; effect on hemostatic variables and other coronary risk factors. Nutrition Metabolism and Cardiovascular Diseases 1995: 4: 343-49.
22. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991: 91: 191-205.
23. Björntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990: 10: 493-6.
24. Björntorp P. Abdominal obesity and the developement of non-insulin-dependent diabetes mellitus. Diabetes Metab 1988: Rev 4: 615-22.
25. Mårin P, Andersson B, Ottosson M. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 1992: 41: 1242-8.
26. Vague P, Juhan-Vague I, Aillaud MF, et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986: 35: 250-3.
27. Alessi MC, Juan-Vague I, Kooistra T, DeClerk PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1. Thromb Haemostas 1988: 60: 491-4.
28. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis. Diabetologia 1991: 34: 457-62.
29. Cigolini M, Targher G, Seidell JC, et al. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Atherosclerosis 1994: 106: 139-47.
30. Kluft C, Jie FH, Rijken DC, Verheijen JH. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fastacting inhibitor (PAI-1). Thromb Haemostas 1988: 59: 329-32.
31. Després J-P, Prud'homme D, Pouliot M-C, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991: 54: 471-7.